Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
55M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
12.4M
-
Shares change
-
-2.49M
-
Total reported value, excl. options
-
$29M
-
Value change
-
-$9.29M
-
Number of buys
-
26
-
Number of sells
-
-35
-
Price
-
$2.34
Significant Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q2 2024
75 filings reported holding AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q2 2024.
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.4M shares
of 55M outstanding shares and own 22.53% of the company stock.
Largest 10 shareholders include Blue Water Life Science Advisors, LP (4.7M shares), BlackRock Inc. (1.5M shares), VANGUARD GROUP INC (1.46M shares), GEODE CAPITAL MANAGEMENT, LLC (562K shares), SVB WEALTH LLC (515K shares), STATE STREET CORP (435K shares), Parkman Healthcare Partners LLC (376K shares), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (350K shares), Polar Capital Holdings Plc (330K shares), and Schonfeld Strategic Advisors LLC (294K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.